Thu. 8 Feb 2024, 4:44pm ET
Benzinga
Earnings, News
Sonoma Pharmaceuticals (NASDAQ:SNOA) reported quarterly losses of $(0.08) per share. This is a 87.1 percent increase over losses of $(0.62) per share from the same period last year. The company reported $3.14 million in sales this quarter. This is a 6.59 percent increase over sales of $2.94 million the same period last year.